Skip NavigationSkip to Content

NCI at Frederick Scientific Publications Advanced Search

Search

  1. NCI-F Publications

  2. Return to Quick Search
Search
  2. Year Published:

Your search returned 22 results.
User Information
Export Records
  1. 1.   Are We Making PROGRESS in Preventing Graft-versus-Host Disease and Improving Clinical Outcomes? Impact of BMT CTN 1301 Study Results on Clinical Practice
  2. Hamilton, Betty K; Cutler, Corey; Divine, Clint; Juckett, Mark; LeMaistre, Charles; Stewart, Susan; Wilder, Jennifer; Horowitz, Mary; Khera, Nandita; Burns, Linda J
  3. Transplantation and Cellular Therapy. 2022, May 09;
  1. 2.   Failure to Prevent Severe Graft-Versus-Host Disease in Haploidentical Hematopoietic Cell Transplantation with Post-Transplant Cyclophosphamide in Chronic Granulomatous Disease
  2. Parta,Mark; Hilligoss, Dianne; Kelly, Corin; Kwatemaa, Nana; Theobald, Narda; Zerbe, Christa S; Holland, Steven M; Malech, Harry L; Kang, Elizabeth M
  3. Journal of clinical immunology. 2020, Apr 20;
  1. 3.   The MHC in the era of next-generation sequencing: Implications for bridging structure with function
  2. Petersdorf, Effie W.; Ohuigin,Colm
  3. HUMAN IMMUNOLOGY. 2019, Jan; 80(1): 67-78.
  1. 4.   Allogeneic Hematopoietic Stem-Cell Transplantation for GATA2 Deficiency Using a Busulfan-Based Regimen
  2. Parta, Mark; Shah, Nirali N; Baird, Kristin; Rafei, Hind; Calvo, Katherine R; Hughes, Thomas; Cole, Kristen; Kenyon, Meg; Blacklock Schuver, Bazetta; Cuellar-Rodriguez, Jennifer; Zerbe, Christa S; Holland, Steven M; Hickstein, Dennis D
  3. Biology of Blood and Marrow Transplantation. 2018, Jun; 24(6): 1250-1259.
  1. 5.   Mouse Ly49G2(+) NK cells dominate early responses during both immune reconstitution and activation independently of MHC
  2. Barao, I.; Alvarez, M.; Ames, E.; Orr, M. T.; Stefanski, H. E.; Blazar, B. R.; Lanier, L. L.; Anderson, S. K.; Redelman, D.; Murphy, W. J.
  3. Blood. 2011, Jun; 117(26): 7032-7041.
  1. 6.   Natural killer cells recruited into lymph nodes inhibit alloreactive T-cell activation through perforin-mediated killing of donor allogeneic dendritic cells
  2. Laffont, S.; Seillet, C.; Ortaldo, J.; Coudert, J. D.; Guery, J. C.
  3. Blood. 2008 112(3): 661-671.
  1. 7.   Peyer patches are not required for acute graft-versus-host disease after myeloablative conditioning and murine allogeneic bone marrow transplantation
  2. Welniak, L. A.; Kuprash, D. V.; Tumanov, A. V.; Panoskaltsis-Mortari, A.; Blazar, B. R.; Sun, K.; Nedospasov, S. A.; Murphy, W. J.
  3. Blood. 2006, JAN 1; 107(1): 410-412.
  1. 8.   Differential effects of proteasome inhibition by bortezomib on murine acute graft-versus-host disease (GVHD): delayed administration of bortezomib results in increased GVHD-dependent gastrointestinal toxicity
  2. Sun, K.; Wilkins, D. E. C.; Anver, M. R.; Sayers, T. J.; Panoskaltsis-Mortari, A.; Blazar, B. R.; Weiniak, L. A.; Murphy, W. J.
  3. Blood. 2005, NOV 1; 106(9): 3293-3299.
  1. 9.   Triptolide, a constituent of immunosuppressive Chinese herbal medicine, is a potent suppressor of dendritic-cell maturation and trafficking
  2. Chen, X.; Murakami, T.; Oppenheim, J. J.; Howard, O. M. Z.
  3. Blood. 2005, OCT 1; 106(7): 2409-2416.
  1. 10.   Limiting dilution analysis of interleukin-2 producing helper T-cell frequencies as a tool in allogeneic hematopoietic cell transplantation
  2. Petersen, S. L.; Sidorov, I. A.; Russell, C. A.; Dickmeiss, E.; Vindelov, L. L.
  3. Transplantation. 2005, SEP 15; 80(5): 573-581.
  1. 11.   Rapid conversion of effector mechanisms from NK to T cells during virus-induced lysis of allogeneic implants in vivo
  2. Brehm, M. A.; Daniels, K. A.; Ortaldo, J. R.; Welsh, R. M.
  3. Journal of Immunology. 2005, JUN 1; 174(11): 6663-6671.
  1. 12.   Host conditioning is a primary determinant in modulating the effect of IL-7 on murine graft-versus-host disease
  2. Gendelman, M.; Hecht, T.; Logan, B.; Vodanovic-Jankovic, S.; Komorowski, R.; Drobyski, W. R.
  3. Journal of Immunology. 2004 172(5): 3328-3336.
  1. 13.   Inhibition of acute graft-versus-host disease with retention of graft-versus-tumor effects by the proteasome inhibitor bortezomib
  2. Sun, K.; Welniak, L. A.; Panoskaltsis-Mortari, A.; O'Shaughnessy, M. J.; Liu, H. Y.; Barao, I.; Riordan, W.; Sitcheran, R.; Wysocki, C.; Serody, J. S.; Blazar, B. R.; Sayers, T. J.; Murphy, W. J.
  3. Proceedings of the National Academy of Sciences of the United States of America. 2004 101(21): 8120-8125.
  1. 14.   Dissociation of NKT stimulation, cytokine induction, and NK activation in vivo by the use of distinct TCR-binding ceramides
  2. Ortaldo, J. R.; Young, H. A.; Winkler-Pickett, R. T.; Bere, E. W.; Murphy, W. J.; Wiltrout, R. H.
  3. Journal of Immunology. 2004 172(2): 943-953.
  1. 15.   Antigen-primed CD8(+) T cells can mediate resistance, preventing allogeneic marrow engraftment in the simultaneous absence of perforin-, CD95L-, TNFR1- and TRAIL-dependent killing
  2. Komatsu, M.; Mammolenti, M.; Jones, M.; Jurecic, R.; Sayers, T. J.; Levy, R. B.
  3. Blood. 2003 101(10): 3991-3999.
  1. 16.   PS-341 administration inhibits acute graft-versus-host disease and preserves graft-versus-tumor after allogeneic BMT in advanced tumor-bearing mice
  2. Sun, K.; Welniak, L. A.; Wilkins, D.; Panoskaltsis-Mortari, A.; Blazar, B. R.; Sayers, T. J.; Murphy, W. J.
  3. Blood. 2003 102(11, Part 1): 192A-192A.
  1. 17.   Increased bone marrow allograft rejection by depletion of NK cells expressing inhibitory Ly49 NK receptors for donor class I antigens
  2. Raziuddin, A.; Longo, D. L.; Bennett, M.; Winkler-Pickett, R.; Ortaldo, J. R.; Murphy, W. J.
  3. Blood. 2002 100(8): 3026-3033.
  1. 18.   Immunobiology of natural killer cells and bone marrow transplantation: merging of basic and preclinical studies
  2. Murphy, W. J.; Koh, C. Y.; Raziuddin, A.; Bennett, M.; Longo, D. L.
  3. Immunological Reviews. 2001 181: 279-289.
  1. 19.   Tolerance and alloreactivity of the Ly49D subset of murine NK cells
  2. George, T. C.; Ortaldo, J. R.; Lemieux, S.; Kumar, V.; Bennett, M.
  3. Journal of Immunology. 1999 163(4): 1859-1867.
  1. 20.   Positive recognition of MHC class T molecules by the Ly49D receptor of murine NK cells
  2. George, T. C.; Mason, L. H.; Ortaldo, J. R.; Kumar, V.; Bennett, M.
  3. Journal of Immunology. 1999 162(4): 2035-2043.
  1. 21.   Suppression of Graft-Versus-Host Disease and Amplification of Graft-Versus-Tumor Effects By Activated Natural Killer Cells After Allogeneic Bone Marrow Transplantation
  2. Asai, O.; Longo, D. L.; Tian, Z. G.; Hornung, R. L.; Taub, D. D.; Ruscetti, F. W.; Murphy, W. J.
  3. Journal of Clinical Investigation. 1998 101(9): 1835-1842.
  1. 22.   Differential Effects of the Absence of Interferon-Gamma and Il-4 in Acute Graft-Versus-Host Disease After Allogeneic Bone Marrow Transplantation in Mice
  2. Murphy, W. J.; Welniak, L. A.; Taub, D. D.; Wiltrout, R. H.; Taylor, P. A.; Vallera, D. A.; Kopf, M.; Young, H.; Longo, D. L.; Blazar, B. R.
  3. Journal of Clinical Investigation. 1998 102(9): 1742-1748.
NCI at Frederick

You are leaving a government website.

This external link provides additional information that is consistent with the intended purpose of this site. The government cannot attest to the accuracy of a non-federal site.

Linking to a non-federal site does not constitute an endorsement by this institution or any of its employees of the sponsors or the information and products presented on the site. You will be subject to the destination site's privacy policy when you follow the link.

ContinueCancel